Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2024-05-29 00:00:00 ET · period of report 2024-05-29 · accession 0000950170-24-066177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-29 | 2024-05-29 | AXSM | Jacobson Mark L. | COO | M - OptEx | $1.30 | +13.7K | 13.7K | New | +$17.8K |
| D | 2024-05-29 | 2024-05-29 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $74.31 | -7,910 | 5,783 | -58% | -$587.8K |
| D | 2024-05-29 | 2024-05-29 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -13.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | M | A | 13,693 | $1.30 | 13,693 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-29 | S | D | 7,910 | $74.31 | 5,783 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $73.99 and $74.52. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-29 | M | D | 13,693 | $0.00 | 0 | D | $1.30 · 2015-08-15 to 2024-06-18 | 13,693 Common Stock |